Clinical Trial Update: A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

View source ↗

Summary

This update reports long-term outcomes for hepatitis B patients who participated in previous entecavir trials (Phase IIIb).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B | Status: COMPLETED